At The cell clinic, in regenerative treatments using adipose-derived stem cells, genome analysis is conducted to verify the genetic condition of cultured cells. Genetic variations that may occur during the culture process are evaluated using next-generation sequencing (NGS). By selecting only cells without abnormalities, we aim to further enhance the safety and quality of treatment.

We are dedicated to ensuring quality and reliability in regenerative medicine through:
• An in-house cell processing center (CPC) system
• Quality control by specialized cell culture technicians
• A clinical system based on more than nine years of experience

The press release introduces these initiatives in detail along with related information.